Cargando…

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer

Background: It is urgent to develop robust prognostic biomarkers for non-metastatic colorectal cancer (CRC) patients undergoing surgery. The current study aimed to explore and compare the clinical significance of preoperative and postoperative blood tumor biomarkers including circulating tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dong, Yang, Yingchi, Jin, Lan, Wang, Jin, Zhao, Xiaomu, Wu, Guocong, Zhang, Jinghui, Kou, Tiankuo, Yao, Hongwei, Zhang, Zhongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746136/ https://www.ncbi.nlm.nih.gov/pubmed/31528219 http://dx.doi.org/10.7150/jca.30512

Ejemplares similares

Associations of Postoperative Complications Assessed by Clavien–Dindo Classification and Comprehensive Complication Index with Long-Term Overall Survival in Elderly Patients after Radical CRC Resection
por: Wang, Dong, et al.
Publicado: (2020)

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
por: Yang, Yingchi, et al.
Publicado: (2018)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Nephroblastoma overexpressed protein (NOV) enhances 5-Fu-mediated inhibitory effect of colorectal cancer cell proliferation via JNK/AP-1/caspase-8/caspase-3 pathway
por: Wang, Dong, et al.
Publicado: (2021)

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
por: Gao, Zhaoya, et al.
Publicado: (2023)

Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancer
por: Wang, Zihan, et al.
Publicado: (2022)

Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer
por: Chao, Angel, et al.
Publicado: (2023)

Gold nanorods-mediated efficient synergistic immunotherapy for detection and inhibition of postoperative tumor recurrence
por: Zhang, Yingying, et al.
Publicado: (2021)

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer
por: Li, Ming, et al.
Publicado: (2017)

Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma
por: Chen, Yunyang, et al.
Publicado: (2019)

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies
por: Ma, Jietao, et al.
Publicado: (2016)

Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood
por: Wang, Zhong, et al.
Publicado: (2017)

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction
por: Li, Ming, et al.
Publicado: (2023)

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

Effects of Anesthesia on Postoperative Recurrence and Metastasis of Malignant Tumors
por: Fan, Xiaoqing, et al.
Publicado: (2020)

Enrichment and sensing tumor cells by embedded immunomodulatory DNA hydrogel to inhibit postoperative tumor recurrence
por: Wang, Danyu, et al.
Publicado: (2023)

Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor
por: Xu, Shuai-Shuai, et al.
Publicado: (2019)

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
por: Han, Su-xia, et al.
Publicado: (2014)

A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer
por: Wu, Jiao, et al.
Publicado: (2022)

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
por: Wang, Tingting, et al.
Publicado: (2018)

Postoperative recurrence of desmoid tumors: clinical and pathological perspectives
por: Wang, Yi-fei, et al.
Publicado: (2015)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
por: Shi, Ji‐Hua, et al.
Publicado: (2019)

The taTME learning curve for mid-low rectal cancer: a single-center experience in China
por: Xu, Fengming, et al.
Publicado: (2022)

Correlation Between Poor Defecation Habits and Postoperative Hemorrhoid Recurrence
por: Li, Qing, et al.
Publicado: (2022)

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer
por: Jiang, Donggen, et al.
Publicado: (2018)

Abdomen anatomic characteristics on CT scans as predictive markers for short-term complications following radical resection of colorectal cancer
por: Zhang, Xiao, et al.
Publicado: (2022)

Recurrent idiopathic tumoral calcinosis in a child postoperatively
por: Booth, Garrett S., et al.
Publicado: (2015)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Lin, Po-Han, et al.
Publicado: (2021)

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
por: Yang, Jiani, et al.
Publicado: (2021)

Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2023)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer
por: Yi-Wen, Wang, et al.
Publicado: (2022)

Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer
por: Li, Man, et al.
Publicado: (2014)

Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
por: Wang, Jin, et al.
Publicado: (2014)

Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway
por: Ning, Shili, et al.
Publicado: (2022)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
por: Ou, Guoping, et al.
Publicado: (2019)

Prognostic nutrition index predicts short-term surgical complications in patients with rectal cancer after laparoscopic surgery
por: Xu, Fengming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6h5n7rvqkgo44p6f6f5cevuqsm